(USD) | Sep 2023 | Q/Q |
---|---|---|
Revenue | 46.5MM | -25% |
Gross Profit | 6.5MM | -75% |
Cost Of Revenue | 40MM | +12% |
Operating Income | -40.9MM | +31% |
Operating Expenses | 47.4MM | -17% |
Net Income | -44.3MM | +33% |
R&D | 4.6MM | -21% |
G&A | 17MM | -7% |
Marketing | 25.8MM | -22% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Cutera, Inc. (NASDAQ:CUTR) Q4 2023 Earnings Call Transcript March 21, 2024 Cutera, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. This is the conference operator. Welcome to the Cutera, Inc. Fourth Quarter 2023 Results […]
Q4 2023 Cutera Inc Earnings Call
BRISBANE, Calif., March 21, 2024--Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today reported financial results for the fourth quarter and full-year ended December 31, 2023.
Market forces rained on the parade of Cutera, Inc. ( NASDAQ:CUTR ) shareholders today, when the analysts downgraded...
Cutera ( NASDAQ:CUTR ) Third Quarter 2023 Results Key Financial Results Revenue: US$46.5m (down 26% from 3Q 2022). Net...
BRISBANE, Calif., March 01, 2024--Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023 after the market close on Thursday, March 21, 2024.
MicroVision, Cutera and IRIDEX have been highlighted in this Industry Outlook article.
The Zacks Laser Systems and Components industry participants like MicroVision (MVIS), Cutera (CUTR) and IRIDEX Corporation (IRIX) gain from solid demand for emerging applications like autonomous driving, IoT, 5G and healthcare amid challenging macroeconomic conditions.
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...
BRISBANE, Calif., February 08, 2024--CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced the international limited commercial release of AviClear, the first energy-based device FDA-cleared for the long-term treatment of mild, moderate, and severe acne. AviClear received an enthusiastic reception at this year’s International Master Course on Aging Science (IMCAS) conference in Paris, France, held February 1-3.